Harmony Biosciences Holdings Inc (NASDAQ: HRMY) started the day on Wednesday, with a price increase of 0.13% at $38.49, before settling in for the price of $38.44 at the close. Taking a more long-term approach, HRMY posted a 52-week range of $25.52-$40.93.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.63%. This publicly-traded company’s shares outstanding now amounts to $57.60 million, simultaneously with a float of $48.95 million. The organization now has a market capitalization sitting at $2.22 billion. At the time of writing, stock’s 50-day Moving Average stood at $33.71, while the 200-day Moving Average is $33.13.
Harmony Biosciences Holdings Inc (HRMY) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Harmony Biosciences Holdings Inc’s current insider ownership accounts for 15.02%, in contrast to 83.57% institutional ownership. According to the most recent insider trade that took place on Dec 12 ’25, this organization’s PRESIDENT, CEO sold 25,933 shares at the rate of 40.11, making the entire transaction reach 1,040,103 in total value, affecting insider ownership by 0.
Harmony Biosciences Holdings Inc (HRMY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.03 per share during the current fiscal year.
Harmony Biosciences Holdings Inc’s EPS increase for this current 12-month fiscal period is 25.63% and is forecasted to reach 4.06 in the upcoming year.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) Trading Performance Indicators
Let’s observe the current performance indicators for Harmony Biosciences Holdings Inc (HRMY). It’s Quick Ratio in the last reported quarter now stands at 3.72. Alongside those numbers, its PE Ratio stands at $12.12, and its Beta score is 0.84. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.68. Similarly, its price to free cash flow for trailing twelve months is now 7.47.
In the same vein, HRMY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 3.18, a figure that is expected to reach 0.85 in the next quarter, and analysts are predicting that it will be 4.06 at the market close of one year from today.
Technical Analysis of Harmony Biosciences Holdings Inc (HRMY)
If we take a close look at the recent performances of Harmony Biosciences Holdings Inc (NASDAQ: HRMY), its last 5-days Average volume was 0.7 million that shows plunge from its year to date volume of 0.73 million. During the previous 9 days, stock’s Stochastic %D was recorded 39.38% While, its Average True Range was 55.83.
Raw Stochastic average of Harmony Biosciences Holdings Inc (HRMY) in the period of the previous 100 days is set at 84.50%, which indicates a major rise in contrast to 36.53% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.31 that was higher than 1.11 volatility it exhibited in the past 100-days period.
